Skip to content

Bushen Qingre Runzao decoction for primary Sjogren's syndrome: a randomized controlled trial

Bushen Qingre Runzao decoction for primary Sjogren's syndrome: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003900
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-08
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjogren's syndrome

Interventions

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age of 18 to 75 years; 2. Fulfill the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria, with dry mouth or dry eyes; 3. Fulfill positive autoantibody (ANA or anti-SSA antibody or anti-SSB antibody or RF) and/or hyperimmunoglobulinemia or increased erythrocyte sedimentation rate; 4. Fulfill the Yin deficiency and dryness-heat syndrome; 5. Patients were informed and voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with other connective tissue diseases; 2. Glucocorticoids or biological agents have been used within 3 months before enrollment; 3. Pregnancy, preparation for pregnancy or breastfeeding; 4. Patients with severe mental and neurological disorders; 5. Patients with severe disease of heart, brain, lung, liver, kidney, hematopoietic system, etc.; 6. Patients with definite visual field defects, ocular fundus lesions, and severe arrhythmias (atrial fibrillation, atrioventricular block, etc.); 7. Patients are participating in other drug trials.

Design outcomes

Primary

MeasureTime frame
Oral dryness VAS;

Secondary

MeasureTime frame
Pain VAS score;Eye dryness VAS score;C-reactive protein, CRP;ESSDAI score;SF-36 health survey;??Schirmer??;Erythrocyte sedimentation rate, ESR;Fatigue VAS score;Schirmer tests;Immunoglobulin (IgA, IgM, IgG)of serum;ESSPRI score;

Countries

China

Contacts

Public ContactLuo Jing

China-Japan Friendship Hospital

luojinggg@sina.com+86 15910598716

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026